Sleep duration and sarcopenia in adults aged ≥ 65 years from low and middle-income countries.

Autor: Smith L; Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK., Shin JI; Department of Pediatrics, Yonsei University College of Medicine, Yonsei-ro 50, Seodaemun-gu, 8044, Seoul, 120-752, Republic of Korea., Veronese N; Department of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy., Soysal P; Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey., López Sánchez GF; Division of Preventive Medicine and Public Health, Department of Public Health Sciences, School of Medicine, University of Murcia, 30100, Murcia, Espinardo, Spain. gfls@um.es., Pizzol D; Italian Agency for Development Cooperation, Jerusalem, Israel., Demurtas J; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy., Tully MA; Institute of Mental Health Sciences, School of Health Sciences, Ulster University, Newtownabbey, BT15 1ED, Northern Ireland., Barnett Y; Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK., Butler L; Centre for Health, Performand and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK., Koyanagi A; Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, 08830, Barcelona, Spain.; ICREA, Pg, Lluis Companys 23, 08010, Barcelona, Spain.
Jazyk: angličtina
Zdroj: Aging clinical and experimental research [Aging Clin Exp Res] 2022 Jul; Vol. 34 (7), pp. 1573-1581. Date of Electronic Publication: 2022 Feb 01.
DOI: 10.1007/s40520-022-02074-3
Abstrakt: Background: Sleep duration may influence risk for sarcopenia but studies on this topic are scarce, especially from low and- middle-income countries (LMICs). Thus, the aim of the present study was to investigate the association between sleep duration and sarcopenia among adults aged ≥ 65 years from five LMICs (China, Ghana, India, Russia, South Africa).
Methods: Cross-sectional, community-based data from the WHO study on global ageing and adult health (SAGE) were analysed. Sarcopenia was defined as having low skeletal muscle mass (SMM) and weak handgrip strength, while severe sarcopenia was defined as having low SMM, weak handgrip strength, and slow gait speed. Self-reported sleep duration in the past two nights were averaged and classified as ≤ 6, > 6 to ≤ 9, and ≥ 9 h/day. Multivariable logistic regression analysis was conducted.
Results: Data on 13,210 adults aged ≥ 65 years [mean (SD) age 72.6 (11.3) years; 55.0% females] were analyzed. In the overall sample, compared to > 6 to ≤ 9 h/day of sleep duration, > 9 h/day was associated with 1.70 (95% CI 1.15-2.51) and 1.75 (95% CI 1.08-2.84) times higher odds for sarcopenia and severe sarcopenia, respectively. No significant associations were observed among males, but associations were particularly pronounced among females [i.e., OR = 2.19 (95% CI 1.26-3.81) for sarcopenia, and OR = 2.26 (95% CI 1.20-4.23) for severe sarcopenia].
Conclusions: Long sleep duration was associated with an increased odds of sarcopenia and severe sarcopenia in LMICs, particularly in females. Future studies should investigate whether addressing long sleep duration among females can lead to lower risk for sarcopenia onset in LMICs.
(© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Databáze: MEDLINE
Externí odkaz: